Health Disparities in Underserved Populations

Clinical trials play a vital role in advancing medical research, yet significant barriers prevent diverse participation. This article highlights key obstacles, including geographical limitations, trial accessibility, and communication challenges. Many trials are located far from minority communities, with inconvenient schedules and limited outreach to trusted healthcare providers.

To foster inclusivity, the document emphasizes improving trial design, expanding diverse site selection, and enhancing enrollment strategies. It also aligns with the FDA’s efforts to increase diversity, ensuring research findings reflect broader populations and contribute to more effective, equitable healthcare solutions.